Abstract:Introduction: This study aims to evaluate the use of CT-based whole kidney parenchyma (WKP) segmentation in 177Lu-DOTATATE dosimetry. Specifically, it investigates whether WKP volumes change during treatment and evaluates the accuracy of applying a single delineated WKP volume for dosimetry. Furthermore, it aims to determine the cause of WKP volume changes-whether caused by radiation or amino acid infusion-by comparing them with spleen volume changes as a marker for radiation-induced alterations. Methods: SPECT/CT images of 18 patients were acquired over the abdomen approximately 4 h (h) (D0), 24 h (D1), 48 h (D2) and 168 h (D7) post-administration of 177Lu-DOTATATE. CT guided WKP volumes were measured before (baseline) and during treatment. Kidney activity concentrations at each time point were derived from CT-segmented WKP overlaid on SPECT scans. The accuracy of using WKP segmentation from a single CT for all time points was assessed against the gold standard of segmenting each WKP individually. Time-integrated activity calculations were based on a tri-exponential curve fit of the kidney activity concentration over time. Kidney absorbed doses were estimated under the assumption of local energy deposition. Additionally, the impact of various partial volume correction methods on dosimetry was evaluated. Results: Whole-kidney parenchyma (WKP) volumes, ranging from 31 to 243 mL, showed a gradual increase from baseline (mean ± SD = 130.6 ± 46.1 mL) at the initial time points D0 (138.5 ± 44.7 mL) and D1 (139.4 ± 41.6 mL), followed by a slight decrease at D2 (132.8 ± 44.5 mL) and a further decrease at D7 (129.2 ± 42.7 mL). The volume increase at D0 and D1 was statistically significant. Spleen volume did not change during treatment, suggesting that amino acid infusion rather than irradiation effects caused WKP volume changes. Bland-Altman analysis revealed WKP volume biases of 8.77% (D0 vs. BL), 10.77% (D1 vs. BL), 1.10% (D2 vs. BL), and 1.10% (D7 vs. BL), with corresponding uncertainties of 24.4%, 23.6%, 25.4%, and 25.4%, respectively. When WKP segmentation from a single CT is applied across all SPECTs, these WKP volume changes could overestimate the activity concentration and mean absorbed doses up to 4.3% and 2.5%, respectively. The absorbed dose uncertainties using a recovery coefficient (RC) of 0.85 for single-time-point WKP delineation increase the absorbed dose uncertainty by 4% compared to the use of patient-specific RCs and time specific segmentation of WKP volumes. Conclusions: Kidney volume exhibited significant variation form D0 to D7, affecting the precision of dosimetry calculation, primarily due to errors in whole-kidney parenchyma (WKP) delineation. Notably, using WKP segmentation from a single CT scan applied to sequential SPECT images introduce further uncertainty and may lead to an overestimation of the absorbed dose. The fluctuations in kidney volume are most likely attributable to amino acid infusion.

Anatomy-based correction of kidney PVE on [Formula: see text] SPECT images

Correction of partial volume effect in the projections in PET studies

Anatomical-based Partial Volume Correction for Low-Dose Dedicated Cardiac SPECT/CT

A Deep-Learning–Based Partial-Volume Correction Method for Quantitative 177 Lu SPECT/CT Imaging

Partial volume correction for Lu-177-PSMA SPECT

Partial volume correction of PET image data using geometric transfer matrices based on uniform B-splines

Simultaneous Partial Volume Correction and Noise Regularization for Cardiac SPECT/CT

Correction of partial volume effect in 99mTc-TRODAT-1 brain SPECT images using an edge-preserving weighted regularization

Kidney dosimetry in [ 177 Lu]Lu-DOTA-TATE therapy based on multiple small VOIs

Implementation of a Spatially-Variant and Tissue-Dependent Positron Range Correction for PET/CT Imaging

The Impact of Bayesian Penalized Likelihood Reconstruction Algorithm on Quantitative Accuracy of Volumetric Measurements in Positron Emission Tomography

Noise suppressed partial volume correction for cardiac SPECT/CT.

Partial Volume Effect Corrected Metabolically Active Tumor Volume From Pet For Early-Stage Lung Cancer

PET quantification performance of the oversize-volume-of-interest approach in the context of tumour dosimetry in radionuclide therapy planning

PETPVC: a toolbox for performing partial volume correction techniques in positron emission tomography

Quantitative evaluation of PSMA PET imaging using a realistic anthropomorphic phantom and shell-less radioactive epoxy lesions

Investigation and optimization of PET-guided SPECT reconstructions for improved radionuclide therapy dosimetry estimates

A Blind Deconvolution Method Incorporated with Anatomical‐based Filtering for Partial Volume Correction: Validations with 123i‐mibg Cardiac SPECT/CT

Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy

Image quality evaluation for a clinical organ-targeted PET camera

Quantification performance of silicon photomultiplier-based PET for small 18F-, 68Ga- and 124I-avid lesions in the context of radionuclide therapy planning